Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT01089010

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Phoenix Neurological Associates, Ltd. Phoenix, Arizona, United States
  • University Neurology Associates Fresno, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
View all 15 locations
View Trial Details
Completed

A Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT01378676

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • California Pacific Medical Center San Francisco, California, United States
  • Mayo Florida Jacksonville, Florida, United States
  • University of Kansas Kansas City, Kansas, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Completed

Dose Titration Study to Test Safety and Effects of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT01486849

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of California at San Francisco, Fresno Campus, Central California Neurological Institute Fresno, California, United States
  • Coordinated Clinical Research La Jolla, California, United States
  • University of California at Irvine, ALS and Neuromuscular Center Orange, California, United States
  • Hospital for Special Care New Britain, Connecticut, United States
View Trial Details
Completed

Efficacy, Safety and Tolerability of High Lipid and Calorie Supplementation in Amyotrophic Lateral Sclerosis

NCT02306590

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Department of Neurology, University of Ulm Ulm, Baden-Wurttemberg, Germany
  • Department of Neurology, University of Wuerzburg Würzburg, Bavaria, Germany
  • Department of Neurology, Medical School Hannover Hanover, Lower Saxony, Germany
  • Department of Neurology, University of Rostock Rostock, Mecklenburg-Vorpommern, Germany
View Trial Details

Related conditions